[Neonatal cholestasis]

M L Roquete1

  • 1Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.

Jornal De Pediatria
|December 17, 2003
PubMed

Insights

Early recognition of neonatal cholestasis is crucial for pediatricians. Prompt diagnosis of jaundice after 14 days can significantly improve outcomes for infants with liver conditions.

Area of Science:

  • Pediatrics
  • Neonatology
  • Hepatology

Background:

  • Cholestasis in newborns and infants presents diagnostic challenges.
  • Timely identification is critical for managing various underlying liver diseases.

Purpose of the Study:

  • To alert pediatricians to the importance of early cholestasis recognition in infants.
  • To review key aspects of neonatal cholestasis for improved clinical practice.

Main Methods:

  • Bibliographic research on cholestasis.
  • Focused on relevant publications from the last 30 years using Medline.

Main Results:

  • Describes cholestasis concepts and causes in neonates and infants.
  • Highlights specific conditions like biliary atresia, neonatal hepatitis, galactosemia, and Alagille syndrome.
  • Discusses diagnostic resources for cholestasis.

Conclusions:

  • Diagnosing cholestasis via hyperbilirubinemia in jaundiced newborns after 14 days is a key goal.
  • Early diagnosis can alter the prognosis of several neonatal cholestasis-causing diseases.

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...